The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.
A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...
Wegovy and Zepbound are approved for weight loss. The possible side effects of Rybelsus are similar to those of Ozempic, with nausea being the most reported adverse reaction in clinical trials.
Then he started taking Ozempic, the Novo Nordisk diabetes drug that is sold under the name Wegovy for obesity. He later switched to Mounjaro, from Eli Lilly, which is sold as Zepbound for obesity.
Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen ... the active ingredients in Wegovy and Zepbound, respectively. This study adds to a growing body of research documenting ...
Physicians have warned that a small percentage of patients taking the popular weight loss and diabetes medications Ozempic, Wegovy, Mounjaro, and Zepbound have experienced vision loss. However ...